Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 9;6(4):198.
doi: 10.3390/tropicalmed6040198.

Chagas Disease in People with HIV: A Narrative Review

Eva H Clark  1   2 , Caryn Bern  3
Affiliations
Review

Chagas Disease in People with HIV: A Narrative Review

Eva H Clark et al. Trop Med Infect Dis. .

Abstract

Many questions remain unanswered regarding the epidemiology, pathophysiology, diagnosis, treatment, and monitoring of Trypanosoma cruzi infection in people with HIV (PWH). The reported prevalence of T. cruzi infection in PWH living in endemic countries ranges from 1-28% and is likely similar in at-risk US populations. While classic cardiac and gastrointestinal presentations of chronic Chagas disease occur in PWH, PWH are additionally at risk for a severe and often fatal form of T. cruzi-mediated disease called reactivation disease. T. cruzi reactivation typically occurs in PWH with low CD4 counts and poor virologic control. National HIV guidelines in several endemic South American countries recommend that all PWH be screened for T. cruzi infection at the time of HIV diagnosis; however, this recommendation is not widely implemented. The early detection of T. cruzi infection in PWH is critical as the sequelae of Chagas disease, including T. cruzi reactivation, may be preventable through the restoration of robust cellular immunity via the initiation of antiretroviral therapy and the appropriate use of antitrypanosomal therapy.

Keywords: AIDS; Chagas disease; HIV; Trypanosoma cruzi.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Carlier Y., Torrico F. Congenital infection with Trypanosoma cruzi: From mechanisms of transmission to strategies for diagnosis and control. Rev. Soc. Bras. Med. Trop. 2003;36:767–771. doi: 10.1590/S0037-86822003000600024. - DOI - PubMed
    1. Benchetrit A., Andreani G., Avila M.M., Rossi D., De Rissio A.M., Weissenbacher M., Peralta L.M., Dolcini G. High HIV–Trypanosoma cruzi Coinfection Levels in Vulnerable Populations in Buenos Aires, Argentina. AIDS Res. Hum. Retrovir. 2017;33:330–331. doi: 10.1089/aid.2016.0068. - DOI - PubMed
    1. Diez M.S., Nocito I., De Frade A.R., Cappello S.G., Guillén S.M., Montero A. Serological evidence of cytomegalovirus, hepatitis B and C, Epstein-Barr virus, Toxoplasma gondii, Trypanosoma cruzi and Treponema pallidum in HIV infected patients. Medicina. 2001;61:378–380. - PubMed
    1. Dolcini G., Ambrosioni J., Andreani G., A Pando M., Peralta L.M., Benetucci J. Prevalence of human immunodeficiency virus (HIV)-Trypanosoma cruzi co-infection and injectable-drugs abuse in a Buenos Aires health center. Rev. Argent. Microbiol. 2008;40:164–166. - PubMed
    1. Stauffert D., da Silveira M.F., Mesenburg M.A., Manta A.B., Dutra A.D.S., Bicca G.L.D.O., Villela M.M. Prevalence of Trypanosoma cruzi/HIV coinfection in southern Brazil. Braz. J. Infect. Dis. 2017;21:180–184. doi: 10.1016/j.bjid.2016.10.006. - DOI - PMC - PubMed